Synthesis, characterization, and immunological properties in mice of conjugates composed of detoxified lipopolysaccharide of Salmonella paratyphi A bound to tetanus toxoid, with emphasis on the role of O acetyls

Infection and Immunity

Volumn 64, Issue 7, 1996, Pages 2709-2715

  Konadu, Edward ^a   Shiloach, Joseph ^b   Bryla, Dolores A ^a   Robbins, John B ^a   Szu, Shousun C ^a  

^a EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

^b NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIUM LIPOPOLYSACCHARIDE; IMMUNOGLOBULIN G; TETANUS TOXOID;

ANIMAL EXPERIMENT; ANTIBODY RESPONSE; ANTIGEN RECOGNITION; ARTICLE; BACTERIAL VIRULENCE; CONTROLLED STUDY; FEMALE; IMMUNIZATION; IMMUNOGENICITY; MOUSE; NONHUMAN; PRIORITY JOURNAL; SALMONELLA PARATYPHI;

EID: 0029976899     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/iai.64.7.2709-2715.1996     Document Type: Article

References (76)

1. Acharya, G., T. Butler, M. Ho, P. R. Sharma, M. Tawari, R. K. Adhikari, J. B. Khagda, B. Pokhrel, and U. N. Pathak. 1995 Treatment of typhoid fever: randomized trial of a three-day course of ceftriaxone versus a fourteen-day course of chloramphenicol. Am. J. Trop. Med. Hyg. 52:162-165.
2. Acharya, I. L., C. U. Lowe, R. Thapa, V. L. Gurubacharya, M. B. Shrestha, M. Cadoz, D. Schulz, J. Armand, D. A. Bryla, B. Trollfors, T. Cramton, R. Schneerson, and J. B. Robbins. 1987. Prevention of typhoid fever in Nepal with the Vi capsular polysaccharide of Salmonella typhi. N. Engl. J. Med. 317:1101-1104.
3. Adeyokunnu, A., and R. G. Hendrickse. 1980. Salmonella osteomyelitis in childhood. Arch. Dis. Child. 55:175-184.
4. Anand, A. C, V. K. Kataria, W. Singh, and S. K. Chatterjee. 1990. Epidemic multiresistant enteric fever in eastern India. Lancet 335:352.
5. Avery, O. T., and W. F. Goebel. 1933. Chemoimmunological studies un the soluble specific substance of pneumococcus. I. The isolation and properties of the acetyl polysaccharide of pneumococcus type J. J. Exp. Med. 58:731-755.
6. Baumgartner, J. U., D. Heumann, T. Calandra, and M. P. Glauser. 1991. Antibodies to lipopolysaccharide after immunization of humans with rough mutant Escherichia coli. J. Infect. Dis. 163:769-772.
7. Bhutta, Z. A., B. J. Farooqui, and A. W. Sturm. 1992. Eradication of a multiple drug resistant Salmonella paratyphi A causing meningitis with ciprofloxacin. J. Infect. 25:215-219.
8. Bhutta, Z. A., S. H. Naqvi, R. A. Razzaq, and B. J. Farooqui. 1991. Multi-drug-resistant typhoid in children: presentation and clinical features. Rev. Infect. Dis. 13:832-836.
9. Blaser, M. J., and R. A. Reldman. 1981. Salmonella bacteremia: reports to the Centers for Disease Control, 1968-1979. J. Infect. Dis. 143:743-746.
10. Bock, K., M. Meldal, D. R. Bundle, T. Iversen, P. J. Garegg, T. Norberg, A. A. Lindberg, and S. B. Svensson. 1984. The conformation of Salmonella O. antigenic polysaccharide chains of serogroups A, B, and D′ predicted by semi-empirical hard-sphere (HSEA) calculations. Carbohydr. Res. 130:23-34.
11. 13C-nuclear magnetic resonance spectroscopy. Carbohydr. Res. 130:35-53.
12. Carlin, N. I. A., S. B. Svenson, and A. A. Lindberg. 1987. Role of monoclonal O-antigen antibody epitope specificity and isotype in protection against experimental mouse typhoid. Microb. Pathog. 2:171-183.
13. Celum, C. L., R. E. Chaisson, G. W. Rutherford, J. L. Barnhart, and D. F. Echenberg. 1987. Incidence of salmonellosis in patients with AIDS. J. Infect. Dis. 156:998-1002.
14. Chalker, R. B., and M. J. Blaser. 1988. A review of human salmonellosis. III. Magnitude of Salmonella infection in the United States. Rev. Infect. Dis. 10:111-124.
15. Chu, C., B. Liu, D. Watson, S. C. Szu, D. Bryla, J. Shiloach, R. Schneerson, and J. B. Robbins. 1991. Preparation, characterization and immunogenicity of conjugates composed of the O-specitic polysaccharide of Shigella dysenteriae type 1 bound to tetanus toxoid. Infect. Immun. 59:4450-4458.
16. Colwell, B. E., S. M. Michalek, D. E. Briles, J. Emilio, and J. R. McGhee. 1984. Monoclonal antibodies to Salmonella lipopolysaccharide: anti-O-polysaccharide antibodies protect C3H mice against challenge with virulent Salmonella typhimurium. J. Immunol. 133:950-957.
17. Cygler, M., D. R. Rose, and D. R. Bundle. 1991. Recognition of a cell-surface oligosaccharide of pathogenic Salmonella by an antibody Fab fragment. Science 253:442-445.
18. DeMaria, A., M. A. Johns, H. Berberich, and W. R. McCabe. 1988. Immunization with rough mutants of Salmonella minnesota: initial studies in human subjects. J. Infect. Dis. 158:301-311.
19. Ebong, W. W. 1986. Acute osteomyelitis in Nigerians with sickle cell disease. Ann. Rheum. Dis. 45:911-915.
20. Edwards, P. R., and D. W. Bruner. 1943. The occurrence and distribution of Salmonella types in the United Stales. J. Infect. Dis. 72:58-61.
21. Edwards, P. R., and W. H. Ewing. 1972. Identification of Enterohacteriaceae, 3rd ed., p. 175. Burges Publishing Company, Minneapolis, Minn.
22. Escamilla, J., H. Florez-Ugarte, and M. E. Kilpatrick. 1986. Evaluation of blood clot cultures for isolation of Salmonella typhi, Salmonella paratyphi A, and Brucella melitensis. J. Clin. Microbiol. 24:388-390.
23. Fouquey, C., J. Polonsky, E. Lederer, O. Westphal, and O. Luderitz. 1958. Synthesis of 3,6-didcoxy-D-ribo-hexose (3,6-dideoxy-D-glucose) and its identification with paratose. Nature (London) 182:944.
24. Frankel, G., S. M. C. Newton, G. K. Schoolnik, and B. A. D. Stocker. 1989. Intragenic recombination in a flagellin gene: Characterization of the Hl-j gene of Salmonella typhi. EMBO J. 8:3149-3152.
25. Gerichter, C. B. 1960. The dissemination of Salmonella typhi, Salmonella paratyphi A, and Salmonella paratyphi B through the organs of the white mouse by oral infection. J. Hyg. Camb. 58:307-319.
26. Gupta, R. K., S. C. Szu, R. A. Finkelstein, and J. B. Robbins. 1992. Synthesis, characterization, and some immunological properties of conjugates composed of the detoxified lipopolysaccharide of Vibrio cholerae Ol serotype Inaba bound to cholera toxin. Infect. Immun. 60:3201-3208.
27. Hafiz, S., S. W. Khan, R. Shariff. I. Yazdani, Y. Syed, and T. Hafiz. 1993. Epidemiology of salmonellosis and its sensitivity in Karachi. J. Pak. Med. Assoc. 43:178-179.
28. Hargrett-Bean, N. T., A. T. Pavia, and R. V. Tauxe. 1988. Salmonella isolates from humans in the United States, 1984-1986. Morbid. Mortal. Weekly Rep. 37(SS-2):25-31.
29. Hellerqvist, C. G., B. Lindberg, K. Samuelsson, and A. A. Lindberg. 1971. Structural studies on the O-specific side-chains of the cell-wall lipopolysaccharide from Salmonella paratyphi A var. durazzo. Acta Chem. Scand. 25: 955-961.
30. Hestrin, S. 1949. The reaction of acctylcholine and other carboxylic acid derivatives with hydroxylamine, and its analytical application. J. Biol. Chem. 180:249-261.
31. Hien, T. T., D. B. Bethell, N. T. T. Hoa, J. Wain, T. S. Diep, L. T. Phi, B. M. Cuong, N.M. Duong, P. T. Thanh, A. L. Walsh, N. P. J. Day, and N. J. White. 1995. Short course of ofloxacin for treatment of multidrug-resistant typhoid. Clin. Infect. Dis. 20:915-923.
32. Hochstein, H. D. 1990. Role of the PDA in regulating the Limulus amoebocyte lysate tests, p. 38-49. In R. B. Prior (ed.), Clinical application of the Limulus amoebocyte lysate test. CRC Press. Inc., Boca Raton, Fla.
33. Jude, A., and L. Le Minor. 1948. Salmonella isolées en Indochine au cours d'affections typho-paratyphoidiques. Bull. Soc. Pathol. Exot. 41:129-133.
34. Kabat, E. A., and M. M. Mayer. 1967. Experimental immunochemistry, p. 493-537. Charles C. Thomas, Springfield, III.
35. Kauffmann, F. 1954. Enterobacteriacae, 2nd revised ed., p. 107. Munks-gaard, Copenhagen.
36. Klugman, K. P., H. J. Koornhof, I. T. Gilbertson, J. B. Robbins, R. Schneerson, D. Schulz, M. Cadoz, and Vaccine Advisory Committee. 1987. Protective activity of Vi capsular polysaccharidc vaccine against typhoid fever. Lancet ii:1165-1169.
37. Kohn, J., and M. Wilchek. 1983. 1-Cyano-4-dimethylamino pyridinium tetrafiuoroborate as a cyanylating agent for the covalent attachment of ligand to polysaccharide resins. FEBS Lett. 154:209-210.
38. Konadu, E., J. B. Robbins, J. Shiloach, D. A. Bryla, and S. C. Szu. 1994. Preparation, characterization and immunological properties in mice of Escherichia coli 0157 O-specific polysaccharide-protein conjugate vaccines. Infect. Immun. 62:5048-5054.
39. Lasserre, R., R. P. Sangalang, and L. Santiago. 1991. Three-day treatment of typhoid fever with two different doses of ceftriaxone, compared to 14-day therapy with chloramphenicol: a randomized trial. J. Antimicrob. Chemother. 28:765-772.
40. Leung, M. Simultaneous infection by a sensitive and a multiresistant strain of Salmonella paratyphi A. J. Infect. 30:181-183.
41. Lee, S.-C., P.-H. Yang, W.-B. Shieh, and R. Lasserre. 1994. Bacteremia due to non-typhi Salmonella: analysis of 64 cases and review. Clin. Infect. Dis. 19:693-696.
42. Lees, A., B. Nelson, and J. J. Mond. 1995. Activation of soluble polysaccharide with 1-cyano-4-dimethylaminopyridinium tetrafluoroborate for use in protein-polysaccharide conjugate vaccines and immunological reagents. Unpublished data.
43. Lepage, P., J. Bogaerts, C. van Goethem, M. Ntahorutaba, F. Nsengumuremyi, D. G. Hitimana, J. Vandepitte, J.-P. Butzler, and J. Levy. 1987. Community-acquired bacteremia in African children. Lancet i:1458-1461.
44. Levine, W. C., J. W. Buehler, N. H. Bean, and R. V. Tauxe. 1991. Epidemiology of nontyphoidal Salmonella bacteremia during the human immunodeficiency virus epidemic. J. Infect. Dis. 164:81-87.
45. Mahanta, J. 1994. Drug sensitivity of Salmonella paratyphi A isolated from a suspected outbreak of fever in Dulijan. J. Indian Med. Assoc. 92:49-50.
46. Nesbitt, A., and N. B. Mirza. 1989. Salmonella septicaemias in Kenyan children. J. Trop. Pediatr. 35:35-39.
47. Nguyen, T. A., H. K. Ha, and T. D. Nguyen. 1993. Typhoid fever in South Vietnam, 1990-1993. Bull. Soc. Pathol. Exot. 86:476-478.
48. Nournand, A., M. Ziai, and A. C. Tahernia. 1971. Typhoid-paratyphoid fevers in infancy. Clin. Pediatr. (Philadelphia) 10:272-274.
49. Ørskov, F., and I. Ørskov. 1983. Summary of a workshop on the clone concept in the epidemiology, taxonomy, and evolution of the Enterobacteriaceae and other bacteria. J. Infect. Dis. 148:346-357.
50. Ørskov, F., I. Ørskov, A. Sutton, R. Schneerson, W. Lin, W. Egan, G. E. Hoff, and J. B. Robbins. 1979. Form variation in Escherichia coli K1 determined by O-acetylation of the capsular polysaccharide. J. Exp. Med. 149:669-685.
51. Peeters, C. A., A.-M. Tenbergen-Meekes, D. E. Evenberg, J. T. Poolman, B. J. M. Zegers, and G. T. Rijkers. 1991. A comparative study of the immunogenicity of pneumococcal type 4 polysaccharide and oligosaccharide tetanus toxoid conjugates in adult mice. J. Immunol. 146:4308-4314.
52. Phillips, I., and B. Wharton. 1968. Acute bacterial infection in kwashiorkor and marasmus. Br. Med. J. 1:407-409.
53. Rao, P. S., I. Bairy, P. V. Rao, and P. G. Shivananda. 1994. Multiresistant Salmonella paratyphi 'A' infection in coastal Karnataka. J. Assoc. Physicians India 42:929.
54. Raynal, J. H., and J. Fournier. 1947. Les salmonelles à Changhaï. Med. Trop. 7:199-237.
55. Reeves, M. W., G. M. Evins, A. A. Heiba, B. D. Plikaytis, and J. J. Farmer III. 1989. Clonal nature of Salmonella typhi and its genetic relatedness to other salmonellae as shown by multilocus enzyme electrophoresis and proposal of Salmonella bongori comb. nov. J. Clin. Microbiol. 27:313-320.
56. Robbins, J. B., C. Y. Chu, and R. Schneerson. 1992. Hypothesis for vaccine development: protective immunity to enteric diseases caused by nontyphoidal Salmonellae and Shigellae may be conferred by serum IgG antibodies to the O-specific polysaccharide of their lipopolysaccharides. Clin. Infect. Dis. 15:346-361.
57. Robbins, J. R., and R. Schneerson. 1990. Polysaccharide-protein conjugates: a new generation of vaccines. J. Infect. Dis. 161:821-832.
58. Robbins, J. B., R. Schneerson, and S. C. Szu. 1995. Perspective: hypothesis: Serum IgG antibody is sufficient to confer protection against infectious diseases by inactivating the inoculum. J. Infect. Dis. 171:1387-1398.
59. Rowe, B., and R. J. Gross. 1984. Genus II. Salmonella, p. 423-458. In N. R. Krieg and J. G. Holt (ed.), Bergey's manual of systemic bacteriology, vol. 1. Williams & Wilkins, Baltimore.
60. Schwartz, E., D. R. Schlim, M. Eaton, N. Jenks, and R. Houston. 1988. The effect of oral and parenteral typhoid vaccination on the rate of infection with Salmonella typhi and Salmonella paratyphi A among foreigners in Nepal. Arch. Intern. Med. 150:349-351.
61. Schwartzer, T. A., D. V. Alcid, V. Numsuwan, and D. J. Gocke. 1988. Characterization of the human antibody response to an Escherichia coli O111:B4 (J5) vaccine. J. Infect. Dis. 158:1135-1136. (Letter.)
62. Simanjuntak, C. H., F. P. Paleologo, N. H. Punjabi, R. Darmowigoto, H. Totosudirjo, P. Haryanto, E. Suprijanto, N. D. Witham, and S. L. Huffman. 1991. Oral immunization against typhoid fever in Indonesia with Ty21a vaccine. Lancet 338:1055-1059.
63. Svensson, S. B., and A. A. Lindberg. 1981. Artificial Salmonella vaccines: Salmonella typhimurium O-antigen-specific oligosaccharide-protein conjugates elicit protective antibodies in rabbits and mice. Infect. Immun. 32:490-496.
64. Syverton, J. T., R. E. Ching, and A. B. Smith. 1946. Typhoid and paratyphoid A in immunized military personnel. JAMA 131:507-514.
65. Szu, S. C., R. Gupta, and J. B. Robbins. 1994. Induction of scrum vibriocidal antibodies by O-specific polysaccharide-protein conjugate vaccines for prevention of cholera, p. 381-394. In I. K. Wachsmuth, P. A. Blake, and O. Olsvik (ed.), Vibrio cholerae. American Society for Microbiology, Washington, D.C.
66. Szu, S. C., X. Li, R. Schneerson, J. H. Vickers, D. A. Bryla, and J. B. Robbins. 1989. Comparative immunogenicities of Vi polysaccharide-protein conjugates composed of cholera toxin or its B subunit as a carrier bound to high-or lower-molecular-weight Vi. Infect. Immun. 57:3823-3827.
67. Szu, S. C., X. Li, A. L. Stone, and J. B. Robbins. 1991. Relation between the structure and immunologic properties of the Vi capsular polysaccharide. Infect. Immun. 59:4555-4561.
68. Taylor, D. N., A. C. Trofa, J. Sadoff, C. Chu, D. Bryla, J. Shiloach, D. Cohen, S. Ashkenazi, Y. Lerman, W. Egan, R. Schneerson, and J. B. Robbins. 1993 Synthesis, characterization and clinical evaluation of conjugate vaccines composed of the O-specific polysaccharides of Shigella dysenteriae type 1, Shigella flexneri type 2a, and Shigella sonnei (Plesiomonas shigelloides) bound to bacterial toxoids. Infect. Immun. 61:3678-3687.
69. Thisyakorn, U., P. Mansuwan, and D. N. Taylor. 1987. Typhoid and paratyphoid fever in 192 hospitalized children in Thailand. Am. J. Dis. Child. 141:862-865.
70. Tsai, C.-M. 1986. The analysis of lipopolysaccharide (endotoxin) in meningococcal polysaccharide vaccines by silver staining following SDSPAGE. J. Biol. Stand. 14:25-33.
71. Verghese, S. L., R. Manonmani, S. Balasubramanian, and S. Chandrasekharan. 1992. Multi-drug resistance in salmonellae isolated from enteric fever cases at Porur-a semi urban area near Madras City. J. Commun. Dis. 24:12-15.
72. Watson, D. C., J. B. Robbins, and S. C. Szu. 1992. Protection of mice against Salmonella typhimurium with an O-specific polysaccharide-protein conjugate vaccine. Infect. Immun. 60:4679-4686.
73. Webb, K. H., and G. R. Sergeant. 1989. Systemic Salmonella infections in sickle cell anaemia. Ann. Trop. Paediatr. 3:169-172.
74. Westphal, O., and K. Jann. 1965. Bacterial lipopolysaccharide extraction with phenol-water and further application of the procedure. Methods Carbohydr. Chem. 5:83-91.
75. Zarkowsky, H. S., D. Gallagher, F. M. Gill, W. C. Wang, J. M. Falletta, W. M. Lande, P. S. Levy, J. I. Verter, D. Wethers, and The Cooperative Study of Sickle Cell Disease, 1986. Bacteremia in sickle hemoglobinopathies. J. Pediatr. 109:579-585.
76. Zimmerman, L. E., M. Cooper, and C. D. Graber. 1952. Bacteriologic studies in an outbreak of salmonellosis in Korea. Am. J. Hyg. 56:252-264.